Keyphrases
Lipopolysaccharide-induced
100%
Lipopolysaccharide Endotoxin
100%
IL-1 Receptor
100%
Lonicerae Flos Extract
100%
Lipopolysaccharide
33%
Activator protein-1 (AP-1)
33%
Nuclear factor-B
33%
Peritoneal Macrophages
33%
Major Constituents
33%
Chlorogenic Acid Isomers
33%
Molecular Mechanism
16%
Healthy Volunteers
16%
Phase I Trial
16%
C57BL
16%
Toll-like
16%
Protective Effect
16%
Induced Expression
16%
Induced Activation
16%
Anti-inflammatory Therapy
16%
Kinase Activity
16%
Receptor Agonist
16%
High Mobility Group Box 1 (HMGB1)
16%
Interleukin-1β
16%
Autophosphorylation
16%
Nitric Oxide Production
16%
Tumor Necrosis Factor-α
16%
Chlorogenic Acid
16%
Endotoxemia
16%
Inflammatory Genes
16%
Intravenous Treatment
16%
Escherichia Coli Lipopolysaccharide
16%
Interleukin-1 Receptor-associated Kinase 4
16%
Cell-free Reactions
16%
Pharmacology, Toxicology and Pharmaceutical Science
Lipopolysaccharide
100%
Endotoxin
100%
Interleukin 1 Receptor Associated Kinase 4
100%
Lonicera
100%
Chlorogenic Acid
42%
Alternative Complement Pathway C3 C5 Convertase
28%
Synapsin I
28%
Nuclear Factor
28%
Normal Human
14%
Phase I Trials
14%
Anti-Inflammatory Drug
14%
C57BL 6 Mouse
14%
Tumor Necrosis Factor
14%
Phosphotransferase
14%
Cytokine
14%
Interleukin 1
14%
Endotoxemia
14%
Toll Like Receptor Agonist
14%
Escherichia Coli Lipopolysaccharide
14%
Nitric Oxide
14%